OrthoPediatrics Corp (STU:2X7)
€ 22.4 1.2 (5.66%) Market Cap: 531.86 Mil Enterprise Value: 528.61 Mil PE Ratio: 0 PB Ratio: 1.49 GF Score: 70/100

Q1 2022 OrthoPediatrics Corp Earnings Call Transcript

May 05, 2022 / 12:00PM GMT
Operator

Welcome to the Q1 2022 OrthoPediatrics Corporation Earnings Conference Call. (Operator Instructions) And I'd now like to turn the call over to Matt Bacso. Matt, you may begin.

Matthew James Bacso
Gilmartin Group LLC - Principal

Thank you for joining today's call. With me from the company are David Bailey, President and Chief Executive Officer; and Fred Hite, Chief Operating and Financial Officer. Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

These forward-looking statements are subject to numerous risks and uncertainties and the company's actual results may differ materially. For a discussion of risk factors, including, among others, the risks related to COVID-19, the impact this pandemic may have on the demand of the company's products and the company's ability to respond to the related challenges, I encourage you to review the company's most recent annual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot